Several market players such as Novo Nordisk and Boston Immune Technologies and Therapeutics are involved in #mergersandacquisitions activities. Click @ https://lnkd.in/d_vZ226Q to capitalize on emerging opportunities that drive innovation in prediabetes management solutions. #gvr #healthcare #healthcareindustry #prediabetes #diabetes
Healthcare | GVR’s Post
More Relevant Posts
-
𝐈𝐧𝐭𝐫𝐚𝐯𝐞𝐧𝐨𝐮𝐬 𝐈𝐧𝐟𝐮𝐬𝐢𝐨𝐧 𝐏𝐮𝐦𝐩: 𝐀 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰(𝐞-𝐏𝐃𝐅 𝐆𝐮𝐢𝐝𝐞) 𝐆𝐞𝐭 𝐚 𝐒𝐚𝐦𝐩𝐥𝐞 𝐞-𝐏𝐃𝐅 𝐨𝐟 𝐫𝐞𝐩𝐨𝐫𝐭 — https://lnkd.in/dRNyi4Py The global #intravenous #infusion #pump market size is expected to reach USD 9.9 billion by 2030 and is expected to expand at 8.3% CAGR from 2023 to 2030, according to a new report by Grand View Research, Inc. The introduction and development of specialty and smart pumps are responsible for the crucial growth of the infusion pump industry. Smart infusion pumps are considered an advancement that will give a boost to the market as it embeds error-reduction software and customized drug libraries. According to a study conducted by Mindray Medical company in 2018, infusion pumps are the most conventional #hospital rental #equipment. #gvr #marketresearch #globalmarket #marketindustry #research
To view or add a comment, sign in
-
🌟Breaking New Ground in Immersive Therapeutics Reimbursement! 🌟 We are delighted to share insights from a compelling case study published by the Medical Device Innovation Consortium (MDIC) featuring our very own, Liesl Oldstone, PhD, MBA, RPh, in collaboration with AppliedVR. This study showcases our journey in securing reimbursement for the RelieVRx program, a virtual reality therapeutic device. 🔍 Key Takeaways: 1️⃣ Real-World Application: Through our efforts, the RelieVRx® program became the first immersive VR (virtual reality) therapeutic to be included in the existing benefit category for durable medical equipment (DME), marking a significant milestone in reimbursement strategy. This case study serves as a practical guide for medtech firms navigating reimbursement challenges, demonstrating how regulatory and reimbursement policies can be applied effectively. 2️⃣ Broadens access to Innovative Treatments: Our reimbursement strategy isn't just about financial reimbursement; it's about broadening access to effective, non-pharmacological treatments. 3️⃣ Valuable Lessons: We view our successful reimbursement strategy as not just a win for AppliedVR but as a significant milestone for the entire healthcare industry. By sharing our real-world example and insights, we aim to pave the way for other companies navigating the reimbursement landscape for new healthcare technologies. We are excited about the potential implications for future research, policy, and practice regarding reimbursement for innovative healthcare solutions. Read the full study here: https://lnkd.in/eJUrA-iZ #Reimbursement #Innovation #Healthcare #MedTech #MDIC #AppliedVR #headsinheadsets #DigitalHealth
To view or add a comment, sign in
-
The radiofrequency (RF) ablation segment held the largest share of 70.7% in 2023, driven by rapid technological advancements and increasing demand for minimally invasive treatment options. Gather comprehensive insights on the Ablation Catheters market @ https://lnkd.in/dx4h9mrE #GVR #healthcare #healthtech #MedTech #catheter #ablation #ablationcatheters #cryoablation
To view or add a comment, sign in
-
📍 Drug treatments and prescriptions are relevant for mutual trust between patients and doctors. When information is not complete or correct, it can cause problems with sometimes devastating consequences. 🔸 Patients risk severe reactions, uncertain results and other adverse effects if they take their medications incorrectly, forget directions, or don't comply with them due to a misunderstanding or other possible reasons. 🔸 Moreover, unsuspecting patients can suffer harm by the increasing amount of counterfeit and poorly manufactured medication that has permeated the market. 🔸 We offer a solution to these problems: Aimedis Avalon uses web3 technology and retail places that enable access to medication in a safe and easy way while providing patients with the necessary comprehensive information about it. We also connect patients worldwide to trusted labs, services for homecare and ambulatory services. ℹ️ For more information feel free to join our Telegram group: https://lnkd.in/dBx85en9 #metaverse #healthcare #AI #medicine #medical #doctors #health #ehealth #Web3 #DeSci #NFTs #NFT #VirtualReality #AR #VR #AIMEDIS #AIMX $AIMX #Medtwitter #medstudents #HealthcareRevolution #education #therapies #pharma #HealthTech #MedicalResearch #FutureOfMedicine
To view or add a comment, sign in
-
#DTx company, Smileyscope, has received FDA clearance for Smileyscope Therapy, now the first VR device to receive FDA Class II clearance for acute pain, and the first and only VR Analgesic available in the US. Read more on this breakthrough and its industry implications here ➡️ https://lnkd.in/eD4bueP6 #digitaltherapeutics #neuromodulation
HealthXL
portal-beta.healthxl.com
To view or add a comment, sign in
-
See what trends are expected to shape the #MedTechindustry in 2024. The MedTech landscape in 2024 is brimming with promise, with groundbreaking innovations poised to redefine healthcare. From the integration of #AR and #VR to #generativeAI, the coming year holds immense potential to reshape the healthcare experience.
Top MedTech Trends in 2024
share.postbeyond.com
To view or add a comment, sign in
-
Enterprise Software Executive at PTC. Customer-centric and results driven sales professional . Passionate about driving measurable value for our customers through digital transformation.
See what trends are expected to shape the #MedTechindustry in 2024. The MedTech landscape in 2024 is brimming with promise, with groundbreaking innovations poised to redefine healthcare. From the integration of #AR and #VR to #generativeAI, the coming year holds immense potential to reshape the healthcare experience.
Top MedTech Trends in 2024
share.postbeyond.com
To view or add a comment, sign in
-
We made waves at #eMergeAmericas10 at our #Healthtech Innovation Hub in collaboration with Jackson Health System. Here's a glimpse into the groundbreaking advancements showcased: 🏥 VR transforming medical spaces for optimized for #PatientCare. 💊 Personalized medicine with MILBox, a revolutionary creation that captures a wide range of patient data to create a "digital twin" that can enable personalized treatments for better outcomes. 💡 #Innovative use of ultrasound energy in patients with uncontrolled hypertension that enhances patient quality of life. 🧠 #AI driving #cardiovascular advancement to enhance precision in #HeartDisease interventions. 👤 Secure #patient data management by streamlining access to medical information for a seamless #PatientExperience. We’re committed to pushing boundaries and transforming patient care. Learn more about the #UHealthDifference: https://loom.ly/mGuqvBQ
To view or add a comment, sign in
-
Rising adoption of outsourcing services due to associated benefits such as cost-effectiveness, and access to specialized expertise are a few factors driving the Medical Device Design And Development Services Market, registering a CAGR of 13.2% from 2024 to 2030. Know more @ https://lnkd.in/d6vDR8-T. #gvr #healthcare #healthcareindustry #medicaldevices #medicaldeviceindustry #medicalservices
To view or add a comment, sign in
-
🧠 Revolutionizing Alzheimer's Disease Assessment with Altoida, Inc.'s AR Technology Altoida announces groundbreaking results from the RADAR-AD consortium study, published in Nature Digital Medicine. The study validates Altoida's augmented reality (AR) and machine learning (ML)-based digital cognitive assessment as a key tool in early Alzheimer’s Disease (AD) identification. Key Highlights: 📱 Innovative AR and ML Integration: Altoida's AR app combines AR and ML to enhance early detection of AD, offering a more objective and frequent assessment. 🧪 RADAR-AD Study Insights: Involving 121 participants, the study shows Altoida’s AR app can distinguish between different stages of AD more effectively than standard cognitive tests. 🎯 Accurate and Early Detection: The app’s ability to detect subtle cognitive changes in preclinical AD stages is particularly significant, aiding in early diagnosis. 🔍 Daily Life Simulation: The AR app simulates instrumental activities of daily living (IADL), making the assessment more relevant and practical. 🚀 Future of AD Monitoring: This technology represents a shift towards more sensitive, objective, and continuous monitoring of AD symptoms, crucial in the era of emerging Alzheimer's drugs. Altoida's commitment to enhancing AR-based cognitive assessments underlines the potential of digital technology in transforming neurological disease management. 🤔 How do you see digital technologies like AR influencing the future of healthcare diagnostics? https://lnkd.in/eB_dUggZ #DigitalHealth #AlzheimersResearch #AugmentedReality #MachineLearning #HealthTechInnovation
Metaverse News & Latest Stories | Metaverse Insider
https://metaverseinsider.tech
To view or add a comment, sign in
645 followers